AI Tokens
Stock Analysis on Net

Intuitive Surgical Inc. (NASDAQ:ISRG)

Common-Size Income Statement
Quarterly Data

Intuitive Surgical Inc., common-size consolidated income statement (quarterly data)

Microsoft Excel
3 months ended: Sep 30, 2026 Jun 30, 2026 Mar 31, 2026 Dec 31, 2025 Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Product 84.18 83.67 84.35 85.28 84.20 83.97 83.89 85.61 83.86 84.21 83.42 84.21 83.20 83.64 83.30 84.09 83.31 83.46 83.24 84.65 83.42 84.43 83.17
Service 15.82 16.33 15.65 14.72 15.80 16.03 16.11 14.39 16.14 15.79 16.58 15.79 16.80 16.36 16.70 15.91 16.69 16.54 16.76 15.35 16.58 15.57 16.83
Revenue 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Product -26.17 -26.86 -28.15 -28.25 -27.92 -28.12 -29.76 -27.51 -27.25 -26.84 -29.32 -29.11 -28.07 -28.36 -29.06 -27.82 -27.07 -27.66 -26.71 -26.76 -25.35 -25.55 -24.71
Service -5.47 -5.36 -5.79 -5.31 -5.72 -5.57 -5.55 -4.45 -5.34 -4.87 -4.80 -4.65 -4.99 -4.90 -5.32 -5.06 -5.37 -5.11 -5.42 -4.83 -5.42 -4.53 -5.43
Cost of revenue -31.63% -32.22% -33.94% -33.56% -33.64% -33.69% -35.31% -31.96% -32.59% -31.70% -34.13% -33.76% -33.06% -33.26% -34.38% -32.88% -32.45% -32.77% -32.13% -31.59% -30.78% -30.08% -30.14%
Gross profit 68.37% 67.78% 66.06% 66.44% 66.36% 66.31% 64.69% 68.04% 67.41% 68.30% 65.87% 66.24% 66.94% 66.74% 65.62% 67.12% 67.55% 67.23% 67.87% 68.41% 69.22% 69.92% 69.86%
Selling, general, and administrative -20.78 -21.36 -22.13 -23.97 -22.89 -23.00 -25.00 -25.38 -25.05 -26.14 -26.00 -29.41 -25.92 -26.44 -28.33 -29.87 -28.00 -27.49 -26.29 -27.54 -25.89 -23.92 -25.23
Antitrust class action litigation settlement -14.76 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Research and development -13.39 -12.81 -13.06 -12.31 -13.15 -12.84 -14.03 -12.21 -14.03 -13.94 -15.05 -13.49 -14.30 -13.92 -14.44 -14.75 -13.94 -13.62 -14.15 -11.83 -11.79 -11.09 -12.37
Operating expenses -48.93% -34.18% -35.20% -36.28% -36.03% -35.84% -39.03% -37.59% -39.09% -40.07% -41.05% -42.90% -40.22% -40.36% -42.77% -44.62% -41.94% -41.11% -40.44% -39.36% -37.68% -35.01% -37.60%
Income from operations 19.44% 33.60% 30.87% 30.15% 30.33% 30.47% 25.65% 30.45% 28.33% 28.23% 24.83% 23.35% 26.71% 26.38% 22.85% 22.51% 25.61% 26.12% 27.43% 29.04% 31.54% 34.92% 32.26%
Interest and other income (expense), net 2.49 2.86 3.07 3.19 3.81 3.64 4.01 3.10 4.60 4.34 3.65 3.41 3.22 2.05 2.02 1.34 0.25 0.61 -0.38 0.25 1.32 1.02 2.48
Income before taxes 21.92% 36.46% 33.94% 33.34% 34.14% 34.10% 29.67% 33.55% 32.92% 32.56% 28.48% 26.75% 29.94% 28.43% 24.87% 23.85% 25.86% 26.73% 27.05% 29.29% 32.86% 35.94% 34.73%
Income tax (expense) benefit -4.72 -8.00 -4.13 -5.45 -5.83 -6.88 1.56 -5.05 -4.93 -6.12 0.47 4.92 -5.86 -4.17 -3.60 -3.50 -5.01 -6.13 -2.22 -4.61 -5.27 -0.22 -1.05
Net income 17.20% 28.46% 29.81% 27.89% 28.31% 27.22% 31.23% 28.51% 28.00% 26.44% 28.95% 31.67% 24.08% 24.26% 21.27% 20.34% 20.85% 20.60% 24.83% 24.68% 27.59% 35.72% 33.68%
Net income attributable to noncontrolling interest in joint venture -0.05 -0.18 -0.16 -0.16 -0.19 -0.24 -0.24 -0.10 -0.27 -0.23 -0.13 -0.23 -0.24 -0.30 -0.32 -0.71 -0.04 -0.38 -0.26 -0.14 -0.48 -0.40 -0.69
Net income attributable to Intuitive Surgical, Inc. 17.15% 28.29% 29.65% 27.73% 28.12% 26.98% 30.99% 28.41% 27.73% 26.22% 28.82% 31.44% 23.84% 23.96% 20.95% 19.63% 20.80% 20.22% 24.57% 24.54% 27.11% 35.33% 32.99%

Based on: 10-Q (reporting date: 2026-09-30), 10-Q (reporting date: 2026-06-30), 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31).


The common-size income statement reveals a stable revenue mix and a general trend toward improved operational efficiency, despite periodic fluctuations in gross margins and a significant non-recurring expense in the final reported period.

Revenue Composition
Revenue streams remain remarkably consistent over the analyzed period. Product revenue consistently accounts for approximately 83% to 85% of total revenue, while service revenue fluctuates within a narrow band between 14% and 17%. This indicates a steady reliance on hardware and consumable sales as the primary driver of growth, complemented by a stable secondary stream of service-based income.
Gross Profitability and Cost of Revenue
Gross profit margins exhibited a period of compression between early 2021 and early 2023, declining from 69.86% to a low of 64.69% in March 2023. This trend coincided with an increase in the cost of revenue, which rose from roughly 30% to a peak of 35.31%. However, a recovery phase followed, with gross margins trending upward again to reach 68.37% by September 2026, suggesting improved cost management or pricing adjustments.
Operating Expense Trends
A notable reduction in Selling, General, and Administrative (SG&A) expenses as a percentage of revenue is observed, decreasing from 25.23% in March 2021 to 20.78% by September 2026. Research and Development (R&D) expenditures remained relatively stable, generally oscillating between 11% and 15% of revenue. While total operating expenses generally trended downward from 2022 peaks, a sharp spike to 48.93% occurred in September 2026, driven exclusively by a one-time antitrust class action litigation settlement equal to 14.76% of revenue.
Operating and Net Income Performance
Income from operations typically ranged between 22% and 35% of revenue for the majority of the period. The stability of this metric was interrupted in the final quarter of the data set, where the aforementioned litigation settlement reduced operating income to 19.44%. Net income attributable to the company followed a similar pattern of resilience, generally staying between 20% and 31%, before dropping to 17.15% in September 2026 due to the non-recurring legal expense.
Other Income and Tax Impact
Interest and other income provided a consistent positive contribution to the bottom line, typically adding between 1% and 4% to the pre-tax income. Income tax expenses showed significant volatility as a percentage of revenue, with several quarters recording tax benefits rather than expenses, which contributed to fluctuations in the final net income margins.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?